Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Zilver Vena Venous Stent

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04812444Not ApplicableCompleted

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

NCT05324787Not ApplicableCompleted

Treatment of Vein Stenosis or Occlusion With the Oblique Stent

Showing all 2 trials

Research Network

Common Treatments

  • Zilver Vena Venous Stent1
  • Grency Venous Stent System1
  • Zylox Peripheral Venous Stent1

Active Sponsors

  • Hangzhou Endonom Medtech Co., Ltd.1
  • Zhejiang Zylox Medical Device Co., Ltd.1

Top Investigators

  • Yu Zhao1

    First Affiliated Hospital of Chongqing Medical University

Related Conditions

  • Iliac Vein Stenosis2

Activity Timeline